01-01-2015 | Original Paper
Topotecan combined with Ifosfamide, Etoposide, and l-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma
Published in: Medical Oncology | Issue 1/2015
Login to get access01-01-2015 | Original Paper
Published in: Medical Oncology | Issue 1/2015
Login to get access